Moreover, primary HIV infection has been shown to cause low-level activation of CD8+ T cells specific for CMV and EBV (and influenza, although this is not a persistent antigen) [40,41] and treating HIV-infected patients with an anti-herpesvirus drug reduced CD8+ T cell activation [42]. This evidence concerns the gene CD8A and HIV infectious disease.